Educational Program Through Video Conference for Inhaled Therapies in Cystic Fibrosis Patients

Cystic Fibrosis Clinical Trial

— Visio-Respir  

Official title:

Evaluation of the Efficacy of an Educational Program Through Video Conference

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03850145
• Other study ID #: RECHMPL19_0054
• Status: Completed
• Start date: February 1, 2019
• Est. completion date: December 30, 2019

Study information

• Verified date: March 2020
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Educational programs are essential for cystic fibrosis patients who need to take several different drugs every day. Compliance is often klow in these patients, and clinicals and paramedics try to increase it, through educational programs. As for inhaled therapies, the CF center of Montpellier uses a video conference tool to educate patients. The program may involve either the physiotherapist or the doctor or both. Through the present study, the investigators would like to evaluate the current practice at the CF center of Montpellier and verify if patients feel that the physiotherapist could handle the program on his own, without the support of a physician.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: December 30, 2019
• Est. primary completion date: December 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• CF patients

• patient regularly assessed at the CF center of Montpellier

• major patients

• patients who recently enrolled a video conference educational program or who will soon be part of it

Exclusion criteria:

• patients not able to participate to a video conference educational program, due to lack of tools at their home

Related Conditions & MeSH terms

• Cystic Fibrosis
• Fibrosis

Locations

Country	Name	City	State
France	Uhmontpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	acceptability of the therapeutic education program by videoconference	acceptability of the therapeutic education program by videoconference with a satisfaction questionnaire	1 day
Primary	need for the presence of the referring physician in relation to a session of therapeutic education carried out by the physiotherapist alone	need for the presence of the referring physician in relation to a session of therapeutic education carried out by the physiotherapist alone with a satisfaction questionnaire	1 day